¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ M}u1qXa  
"9%q bM B  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© o(zTNk5d  
ydB$4ZB3[  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© EavX8r  
| _, /u_  
1.Co-stimulators (or co-stimulating molecules) G0pBR]_5z$  
L_k9g12  
2.NK-kB Qm; BUG]  
NHAH#7]M&1  
3.Immunoglobulin superfamily GkciA{  
St2Q7K5s{  
4.antigen-presenting cell (APC) K#wK1 Sv  
aHC%19UN  
5.death domain 8kS~ENe?o  
ami09JHy  
6.CCR and CXCR P5Dk63z]  
7`dY1.rq  
7.Lectin (or mitogen) kW +G1|  
tt{`\1q  
8.Clusters of differentiation, CD) "wINBya'M  
`m, Ki69.  
9.B7 family M(2`2-/xh  
Yf= FeH7"  
10.Cytotoxic T lymphocyte, CTL) n`.#59-Hx  
H(&Z:{L  
11.IL-15 and IL-15 receptor (IL-15R) {(Fe7,.S3  
lkwh'@s.  
12.MHC restriction GO~k '  
#KE;=$(S  
13.Affinity-chromatography n|C|&  
&D*8l?A/1f  
14.Cyctosprin A, CsA Q.ukY@L.'  
0Cq!\nzz  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 8t[t{"  
U&Ab# m;  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 6#|qg* OS  
;"@:}_t  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 (OqHfv  
Rcf=J){D6  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ [%~^kq=|  
WHk/$7_"i  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ OZT^\Ky_l  
@yKZRwg  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© p8>R#9  
qiU5{}  
ÃâÒßѧרҵ£º BSDk9Oc  
B1+ZFQo  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Yrsp%<qj  
4=s9A  
Ïû»¯ÄÚ¿Æ£º S.hC$0vrj  
n;qz^HXEJ  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ $}4K `Iu  
4|F#gK5E  
ѪҺ²¡Ñ§×¨Òµ£º @G(xaU'u  
9FNwpL'C  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»